522 related articles for article (PubMed ID: 27620308)
1. The Treatment of Venous Thromboembolism in Patients with Cancer.
Prandoni P
Adv Exp Med Biol; 2017; 906():123-135. PubMed ID: 27620308
[TBL] [Abstract][Full Text] [Related]
2. What are the pharmacotherapy options for treating venous thromboembolism in cancer patients?
Prandoni P; Piovella C; Filippi L; Vedovetto V; Dalla Valle F; Piccioli A
Expert Opin Pharmacother; 2014 Apr; 15(6):799-807. PubMed ID: 24548179
[TBL] [Abstract][Full Text] [Related]
3. Treating patients with cancer and acute venous thromboembolism.
Donadini MP; Squizzato A; Ageno W
Expert Opin Pharmacother; 2016; 17(4):535-43. PubMed ID: 26606049
[TBL] [Abstract][Full Text] [Related]
4. The Role of New Oral Anticoagulants (NOACs) in Cancer Patients.
Ravikumar R; Lim CS; Davies AH
Adv Exp Med Biol; 2017; 906():137-148. PubMed ID: 27620312
[TBL] [Abstract][Full Text] [Related]
5. New anticoagulants in the treatment of patients with cancer-associated venous thromboembolism.
den Exter PL; Kooiman J; van der Hulle T; Huisman MV
Best Pract Res Clin Haematol; 2013 Jun; 26(2):163-9. PubMed ID: 23953904
[TBL] [Abstract][Full Text] [Related]
6. New anticoagulants in the treatment of VTE.
Le Gal G; Mottier D
Semin Respir Crit Care Med; 2012 Apr; 33(2):191-8. PubMed ID: 22648492
[TBL] [Abstract][Full Text] [Related]
7. [Venous thrombo-embolic disease in cancer. Low molecular weight heparin indications].
Nou M; Laroche JP
J Mal Vasc; 2016 May; 41(3):197-204. PubMed ID: 27146099
[TBL] [Abstract][Full Text] [Related]
8. Treatment of venous thromboembolism in cancer patients.
Petralia GA; Kakkar AK
Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
[TBL] [Abstract][Full Text] [Related]
9. The treatment of venous thromboembolism in patients with cancer.
Prandoni P
Intern Emerg Med; 2010 Oct; 5 Suppl 1():S27-30. PubMed ID: 20865471
[TBL] [Abstract][Full Text] [Related]
10. Vitamin K antagonists in anticoagulant therapy of patients with cancer.
Pasierski T
Pol Arch Med Wewn; 2012; 122(1-2):60-4. PubMed ID: 22353708
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of venous thrombosis in cancer patients: practical aspects].
Laza-Achille M; Desruennes E; Di Palma M
Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
13. Dose escalation of low molecular weight heparin in patients with recurrent cancer-associated thrombosis.
Ihaddadene R; Le Gal G; Delluc A; Carrier M
Thromb Res; 2014 Jul; 134(1):93-5. PubMed ID: 24835673
[TBL] [Abstract][Full Text] [Related]
14. Safety of anticoagulant treatment in cancer patients.
Wilts IT; Bleker SM; Van Es N; Büller HR; Di Nisio M; Kamphuisen PW
Expert Opin Drug Saf; 2015 Aug; 14(8):1227-36. PubMed ID: 26059964
[TBL] [Abstract][Full Text] [Related]
15. LMWH in cancer patients with renal impairment - better than warfarin?
Bauersachs RM
Thromb Res; 2016 Apr; 140 Suppl 1():S160-4. PubMed ID: 27067971
[TBL] [Abstract][Full Text] [Related]
16. Long-term therapy of venous thromboembolism in cancer patients.
Streiff MB
J Natl Compr Canc Netw; 2006 Oct; 4(9):903-10. PubMed ID: 17020668
[TBL] [Abstract][Full Text] [Related]
17. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
[TBL] [Abstract][Full Text] [Related]
18. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism.
Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G
J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment of deep-vein thrombosis with low-molecular-weight heparin: an update of the evidence.
Hull RD; Townshend G
Thromb Haemost; 2013 Jul; 110(1):14-22. PubMed ID: 23615656
[TBL] [Abstract][Full Text] [Related]
20. Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.
Tran QN
Am J Hosp Palliat Care; 2010 Sep; 27(6):416-9. PubMed ID: 20197558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
